NCT00489307 Dexamethasone for Symptom Burden in Advanced Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00487331 Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study Status COMPLETED Phase NA
NCT00483093 Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor Status COMPLETED Phase PHASE1
NCT00448786 Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00442741 Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) Status WITHDRAWN Phase PHASE1
NCT00428545 Bevacizumab and Bortezomib in Patients With Advanced Malignancy Status COMPLETED Phase PHASE1
NCT00426140 Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. Status COMPLETED Phase PHASE1
NCT00425204 Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment Status COMPLETED Phase PHASE2
NCT00424632 Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00420615 Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00420485 Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00413686 Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies Status COMPLETED Phase PHASE1
NCT00413283 Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00404521 A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors Status TERMINATED Phase PHASE1
NCT00390936 A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00359294 A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma Status TERMINATED Phase PHASE1